
    
      -  Single blind, randomized, prospective study.

        -  Length of experience: 03 days to 07 days.

        -  03 visits (days 1, 4 and 7).

        -  Evaluation of the efficacy and safety of the medication.

        -  Shall be assessed for adverse events.
    
  